Physician profile
Daniel Altman
NPI 1619918828
$1,380.96
in general payments reported to CMS, 2019-2025
16 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.49 · 2020: $106 · 2021: $224 · 2022: $439 · 2023: $226 · 2024: $120 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $510.41 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $278.83 | 2019-2024 | Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $131.63 | 2021-2025 | |
| Lilly USA, LLC | $111.26 | 2020-2023 | Mounjaro |
| Abbvie INC. | $68.52 | 2021-2023 | Vraylar |
| Astrazeneca Pharmaceuticals Lp | $66.99 | 2019-2023 | Fasenra, Breztri |
| Indivior INC. | $55.20 | 2019-2021 | |
| Pfizer INC. | $44.55 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $16.00 | 2023 | Quviviq |
| Arbor Pharmaceuticals, INC. | $15.61 | 2020 | |
| Corcept Therapeutics | $15.12 | 2024 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $14.43 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.38 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $13.79 | 2025 | Abilify Maintena, Abilify Asimtufii |
| Astellas Pharma US INC | $13.02 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $11.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Altman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.